The Next Frontier of Drug Pricing Reform

Wednesday, June 21, at 1:00 p.m. ET / 10:00 a.m. PT

Pharmacy benefit managers are intermediaries that are supposed to negotiate lower drug costs. But does the system work for patients? And how can we fix it when it doesn’t?

Part 1: 

  • U.S. Sen. Chuck Grassley, (R-IA), Ranking Member of the Senate Budget Committee, Former Chairman of the Senate Finance and Judiciary Committees; President Pro Tempore Emeritus
  • Rachel Cohrs, Washington Correspondent, STAT (moderator)

Part 2: 

  • Alex Oshmyansky, MD, Ph.D., CEO and Founder, Mark Cuban Cost Plus Drug Company
  • Ed Silverman, Pharmalot Columnist, Senior Writer, STAT (moderator)

621_VirtualEvent_Sponsor Logo